A Phase 1/2 Study of CBX-12 in Subjects with Advanced or Metastatic Refractory Solid Tumors

Disease:

Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma, Breast Cancer, Colorectal Cancer, Pancreas Cancer, Appendix Cancer, Non-small Cell Lung Cancer, Gastric Cancer, Esophagus Cancer, Urothelial Carcinoma, Sarcoma

Study phase:

Physician name:

Funda Meric-Bernstam

Department:

Investigational Cancer Therapeutics

For general questions about clinical trials:

1-855-939-4993